Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Frazier Life Sciences Public Fund, L.P. reported a 5.10% stake in Lexeo Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 13, 2026

Frazier Life Sciences Public Fund, L.P. reported a 5.10% stake in Lexeo Therapeutics, Inc., 3,698,271 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).

Stake
5.10%
Shares
3,698,271
Intent
Passive
What changed
Stake changed
Filed together
14 holders

The filing in full

HolderStakeShares
Frazier Life Sciences Public Fund, L.P.5.10%3,698,271
FHMLSP, L.P.5.10%3,698,271
FHMLSP, L.L.C.5.10%3,698,271
Frazier Life Sciences X, L.P.0.10%87,424
FHMLS X, L.P.0.10%87,424
FHMLS X, L.L.C.0.10%87,424
Frazier Life Sciences XI, L.P.0.30%232,784
FHMLS XI, L.P.0.30%232,784
FHMLS XI, L.L.C.0.30%232,784
Frazier Life Sciences XII, L.P.0.60%406,246
FHMLS XII, L.P.0.60%406,246
FHMLS XII, L.L.C.0.60%406,246
James N. Topper0.10%87,424
Patrick J. Heron0.10%87,424

Source

View original at SEC

Related